The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

NCT06746194 · clinicaltrials.gov ↗
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Ruijin Hospital